Marocaine Ste de Therapeutique SA (SOT)

Casablanca

Currency in MAD

Disclaimer

930.00

-12.00(-1.27%)

Closed11/10

Fair Value

Day's Range

930.00

942.00

52 wk Range

881.00

1,100.00

SOT Income Statement

Featured here, the Income Statement (earnings report) for Marocaine Ste de Therapeutique SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

1,685.56

1,797.85

2,055.88

2,301.83

2,486

Total Revenues Growth

+7.98%

+6.66%

+14.35%

+11.96%

+8%

Cost Of Revenues

864.9

914.07

1,035.3

1,203.12

1,335.04

Gross Profit

820.67

883.78

1,020.58

1,098.71

1,150.96

Gross Profit Growth

+9.99%

+7.69%

+15.48%

+7.66%

+4.76%

Gross Profit Margin %

48.69%

49.16%

49.64%

47.73%

46.3%

Other Operating Expenses, Total

470.99

488.33

561.16

616.05

756

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.24%	+3.68%	+14.91%	+9.78%	+22.72%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	455.61	471.43	542.4	604.7	683.37
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-23.1	-27.72	-35.86	-45.83	17.99

Operating Income

349.68

395.45

459.41

482.66

394.96

Operating Income Growth

+27.63%

+13.09%

+16.17%

+5.06%

-18.17%

EBIT Margin %

20.75%

22%

22.35%

20.97%

15.89%

Net Interest Expenses

-8.51

-9.78

-8.73

-9.57

-19.9

Net Interest Expenses Growth

+6.31%

-14.95%

+10.74%

-9.62%

-107.92%

Interest Expense, Total

-9.02

-11.08

-9.11

-10.03

-20.36

Interest And Investment Income

0.52

1.3

0.38

0.46

0.47

Other Non Operating Expenses, Total

2.62

-2.35

2.67

6.44

18.95

EBT, Excl. Unusual Items

343.8

383.33

453.35

479.54

394.01

Gain (Loss) On Sale Of Assets

-

1.52

0.03

0

73.34

Other Unusual Items, Total

-23.01

-42.13

-45.96

-56.08

-79.76

EBT, Incl. Unusual Items

320.78

342.72

407.42

416.92

387.6

EBT, Incl. Unusual Items Growth

+29.92%

+6.84%

+18.88%

+2.33%

-7.03%

EBT, Incl. Unusual Items Margin

19.03%

19.06%

19.82%

18.11%

15.59%

Income Tax Expense

101.09

112.46

132.48

149.79

123.85

Net Income to Company

219.69

230.27

274.95

267.13

263.75

Minority Interest

-0.07

-0.07

3.9

-0.52

-0.99

Net Income

219.62

230.2

278.85

266.62

262.76

Net Income Growth

+20.77%

+4.82%

+21.13%

-4.39%

-1.45%

Net Income Margin %

13.03%

12.8%

13.56%

11.58%

10.57%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

219.62

230.2

278.85

266.62

262.76

Basic EPS - Continuing Operations

30.5

31.97

38.73

37.03

36.49

Basic EPS - Continuing Operations Growth

+20.77%

+4.82%

+21.13%

-4.39%

-1.45%

Diluted EPS - Continuing Operations

30.5

31.97

38.7

37

36.49

Diluted EPS - Continuing Operations Growth

+20.79%

+4.83%

+21.04%

-4.39%

-1.37%

Basic Weighted Average Shares Outstanding

7.2

7.2

7.2

7.2

7.2

Diluted Weighted Average Shares Outstanding

7.2

7.2

7.2

7.2

7.2

Dividend Per Share

-

5.25

25

25

17

Dividend Per Share Growth

-

-

+376.19%

0%

-32%

EBITDA

384.78

440.07

514.04

539.84

443.92

EBITDA Growth

+19.98%

+14.37%

+16.81%

+5.02%

-17.77%

EBITDA Margin %

22.83%

24.48%

25%

23.45%

17.86%

EBIT

349.68

395.45

459.41

482.66

394.96

* In Millions of MAD (except for per share items)